Gaudium IVF Q1 FY27 Earnings Call — Analysis (NSE: GAUDIUMIVF)
Gaudium IVF Q1 FY27 revenue grew 9.1% YoY to ₹19.4 Cr while EBITDA margin contracted to 12.5% due to front-loaded expansion costs; management reaffirmed ~30% FY27 revenue growth and expects margins to normalise by year-end.
Result quality: stable — Steady quarter. Management sentiment: neutral.
The take
Gaudium IVF Q1 FY27 revenue grew 9.1% YoY to ₹19.4 Cr while EBITDA margin contracted to 12.5% due to front-loaded expansion costs; management reaffirmed ~30% FY27 revenue growth and expects margins to normalise by year-end.
Results
Revenue ₹19.4 Cr +9.1% YoY; EBITDA ₹2.4 Cr (margin 12.5%, -1651 bps YoY); PAT ₹1.8 Cr (-42.3% YoY); adjusted EBITDA ₹5.35 Cr (margin 27.63%) excluding one-off expansion costs.
Guidance
FY27 revenue growth guided at ~30% YoY, with EBITDA margins recovering to steady-state levels (~27-28%) by year-end.
Key themes
AI-led differentiation and hub expansion execution
Research and educational content only. Not investment advice.